We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Yohimbine HCl
The purified alkaloid (not crude yohimbe bark) — an alpha-2 adrenoceptor antagonist with modest evidence for erectile dysfunction and fasted fat loss, but real anxiety and cardiovascular risks and notoriously mislabeled supplement potency.
What the evidence says
Most Yohimbine studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1993–2021 with a typical study size of 20 participants.
Based on 6 studies · 2 meta-analyses · 2 RCTs · 34 total participants
Confidence
HighBy outcome
Yohimbine has an evidence score of 5/10 — moderate evidence based on 6 indexed studies, including 2 meta-analyses. The purified alkaloid (not crude yohimbe bark) — an alpha-2 adrenoceptor antagonist with modest evidence for erectile dysfunction and fasted fat loss, but real anxiety and cardiovascular risks and notoriously mislabeled supplement potency. Representative study: PMID 9649257.
The commonly studied dose of Yohimbine is Standardized yohimbine HCl ~0.2 mg/kg (roughly 5-15 mg) up to 1-2x daily; start at the lowest dose, ideally fasted for the fat-loss effect. Never combine with other stimulants.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Explore: Best supplements for Vitality & LongevityBest supplements for Athletic PerformanceBest supplements for Men's Health
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
A Moderate 5.0 reflects two meta-analyses supporting yohimbine for erectile dysfunction and a small RCT plus human mechanism work for fasted fat loss, offset by only modest effect sizes, real anxiety and cardiovascular side effects (panic attacks, raised BP/HR), and notoriously inaccurate supplement labeling.
Yohimbine HCl is the standardized, purified alkaloid of the West African yohimbe tree (Pausinystalia johimbe) — distinct from the crude bark, where alkaloid content is wildly variable.
It is an alpha-2 adrenoceptor antagonist: by blocking the pre-synaptic alpha-2 brake on noradrenaline release, it raises sympathetic 'fight-or-flight' tone, which increases lipolysis (especially in 'stubborn' fat depots like the gluteal/thigh region that are dense in alpha-2 receptors) and peripheral blood flow.
That mechanism underpins its two real, if modest, uses. For erectile dysfunction, a 1998 meta-analysis of seven RCTs found yohimbine superior to placebo (OR 3.85), and a 2021 systematic review confirmed a benefit that is clearest when combined with other agents.
For body composition, a small RCT in elite soccer players found ~2% lower body fat over 21 days with no performance change — fat-loss is real but small and most relevant fasted, and not a weight-loss shortcut.
The honest caveats are serious: yohimbine is a stimulant that raises heart rate and blood pressure and reliably provokes anxiety, jitteriness, and outright panic attacks (one clinical study saw panic in 71% of vulnerable subjects). It interacts dangerously with MAOIs, antidepressants, and other stimulants.
Compounding all of this, an analysis of 49 US supplements found yohimbine content ranging from none to 12 mg per serving, most labels inaccurate (23-147% of stated dose), and many omitting any safety warning.
Standardized yohimbine HCl is the only sensible form, started at the lowest dose, and avoided entirely by anyone with cardiovascular or anxiety risk.
Blocks the pre-synaptic alpha-2 'brake' on noradrenaline release, increasing sympathetic noradrenergic tone.
Alpha-2 blockade lifts the antilipolytic, vasoconstrictive brake on fat that is dense in alpha-2 receptors (e.g. gluteal/thigh), increasing lipid mobilization and blood flow — strongest in the fasted state.
Sympathetic and vascular changes can improve erectile function, the best-supported clinical use.
How Yohimbine works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
Standardized yohimbine HCl ~0.2 mg/kg (roughly 5-15 mg) up to 1-2x daily; start at the lowest dose, ideally fasted for the fat-loss effect. Never combine with other stimulants.
Can be taken without food
| Form | Type |
|---|---|
| 💊Standardized yohimbine HCl (known dose) | Recommended |
| 💊Yohimbe bark extract (not recommended — unpredictable potency) | Alternative |
Prefer standardized yohimbine HCl; crude bark has unpredictable, often mislabeled potency.
Minimum: 3 weeks
Optimal: 8 weeks
Cycling: Use intermittently rather than continuously; tolerance and cardiovascular/anxiety load make ongoing daily use inadvisable.
Note: Earlier in the day only, often fasted. Never combine with other stimulants or dose near bedtime.
Dose-response data unavailable. The current published research for Yohimbine does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Small reduction in body fat, most relevant fasted and in stubborn depots — not a weight-loss shortcut.
Moderate benefit for erectile dysfunction vs placebo, clearest when combined with other agents.
Sympathetic stimulation acutely raises heart rate and blood pressure.
Reliably provokes anxiety, jitteriness, and panic attacks, especially in susceptible people and at higher doses.
Yohimbine content in supplements is highly variable and usually mislabeled, making dose and risk hard to predict.
Avoid — yohimbine raises heart rate and blood pressure.
Avoid — reliably provokes anxiety and panic.
Avoid.
Avoid — dangerous interactions.
Risk of a dangerous blood-pressure surge (hypertensive crisis) — do not combine.
Additive noradrenergic effects; raised blood pressure and anxiety.
Tip: Use lowest dose; avoid if any cardiovascular risk
Tip: Take early in the day; reduce dose or stop
Tip: Reduce dose
Tip: Discontinue and seek care; avoid in anxiety/cardiac conditions
The best time to take Yohimbine is in the morning. It can be taken on an empty stomach. Taken earlier in the day, typically fasted, because the lipolytic effect is blunted by insulin and because its stimulant action disrupts sleep.
Yohimbine should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are increased heart rate and blood pressure, anxiety, jitteriness, insomnia, headache, nausea, sweating. Use caution if any of these apply to you: Hypertension or cardiovascular disease; Anxiety, panic, or other psychiatric disorders; Kidney or liver disease.
Reduces cortisol and anxiety while improving sleep quality and physical recovery in stressed adults.
Additive cardiovascular stimulation — raised heart rate/blood pressure, arrhythmia risk.
Yohimbine can counteract antihypertensives and destabilize blood pressure.
May increase blood pressure and side effects.